UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

Correlation of CDA, ERCC1, and XPD Polymorphisms with Response and Survival in Gemcitabine/Cisplatin–Treated Advanced Non–Small Cell Lung Cancer Patients

Clinical cancer research, 2008-03, Vol.14 (6), p.1797-1803

2008

Volltextzugriff (PDF)

Cellular and pharmacogenetics foundation of synergistic interaction of pemetrexed and gemcitabine in human non-small-cell lung cancer cells

Molecular pharmacology, 2005-07, Vol.68 (1), p.110-118

2005

Volltextzugriff (PDF)

Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer

Molecular cancer therapeutics, 2006-06, Vol.5 (6), p.1387-1395

2006

Volltextzugriff (PDF)

Synergistic Cytotoxicity and Pharmacogenetics of Gemcitabine and Pemetrexed Combination in Pancreatic Cancer Cell Lines

Clinical cancer research, 2004-05, Vol.10 (9), p.2936-2943

2004

Volltextzugriff (PDF)

Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines

Molecular cancer therapeutics, 2009-07, Vol.8 (7), p.1964-1973

2009

Volltextzugriff (PDF)

Synergistic Antitumor Activity of ZD6474, An Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor Signaling, with Gemcitabine and Ionizing Radiation against Pancreatic Cancer

Clinical cancer research, 2006-12, Vol.12 (23), p.7099-7107

2006

Volltextzugriff (PDF)

A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge

Cancer chemotherapy and pharmacology, 2007-08, Vol.60 (3), p.459-461

2007

Volltextzugriff (PDF)

Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine

Cancer research (Chicago, Ill.), 2006-04, Vol.66 (7), p.3928-3935

2006

Volltextzugriff (PDF)

Synergistic cytotoxicity, inhibition of signal transduction pathways and pharmacogenetics of sorafenib and gemcitabine in human NSCLC cell lines

Lung cancer (Amsterdam, Netherlands), 2011-11, Vol.74 (2), p.197-205

2011

Volltextzugriff (PDF)

Akt1 rs2498801 is related to survival in head and neck squamous cell cancer treated with radiotherapy

Anticancer research, 2015-01, Vol.35 (1), p.269-271

2015

Volltextzugriff (PDF)

Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer

Cancer chemotherapy and pharmacology, 2010-03, Vol.65 (4), p.679-686

2010

Volltextzugriff (PDF)

Synthesis of Novel 3,5-Disubstituted-2-oxindole Derivatives As Antitumor Agents against Human Nonsmall Cell Lung Cancer

ACS medicinal chemistry letters, 2013-12, Vol.4 (12), p.1137-1141

2013

Volltextzugriff (PDF)

Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma

Laboratory investigation, 2008-07, Vol.88 (7), p.773-784

2008

Volltextzugriff (PDF)

Cytotoxic activity of gemcitabine and correlation with expression profile of drug-related genes in human lymphoid cells

Pharmacological research, 2007-04, Vol.55 (4), p.343-349

2007

Volltextzugriff (PDF)

Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines

Cancer chemotherapy and pharmacology, 2010-08, Vol.66 (3), p.547-558

2010

Volltextzugriff (PDF)

Synergistic Cytotoxicity and Molecular Interaction on Drug Targets of Sorafenib and Gemcitabine in Human Pancreas Cancer Cells

Chemotherapy (Basel), 2010-01, Vol.56 (4), p.303-312

2010

Volltextzugriff (PDF)

Cellular and Pharmacogenetics Foundation of Synergistic Interaction of Pemetrexed and Gemcitabine in Human NonâSmall-Cell Lung Cancer Cells

Molecular pharmacology, 2005-07, Vol.68 (1), p.110

2005

Volltextzugriff (PDF)

242: Pharmacogenetics Determinants of Anticancer Activity of Intravescical Gemcitabine in Patients with Superficial Transitional Cell Carcinoma (TCC) of The Bladder

The Journal of urology, 2007-04, Vol.177 (4), p.81-81

2007

Volltextzugriff (PDF)

D3-06: Correlation of cytidine deaminase and DNA repair genes polymorphisms with response and survival in gemcitabine/cisplatin treated advanced non-small-cell lung cancer patients

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S398-S399

2007

Volltextzugriff (PDF)

THE LEONARDO GALLERY

Leonardo (Oxford), 2000-01, Vol.33 (1), p.3

2000

Volltextzugriff (PDF)

Homage to Escher

Leonardo (Oxford), 2000-01, Vol.33 (1), p.3-16

Emmer, Michele

2000

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Humans
(15)
Life Sciences & Biomedicine
(15)
Science & Technology
(15)
Oncology
(12)
Deoxycytidine - Analogs & Derivatives
(11)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Cell Line, Tumor
(8)
Female
(8)
Antineoplastic Agents
(7)
Pharmacology. Drug Treatments
(7)
Tumors
(7)
Apoptosis - Drug Effects
(6)
Cell Cycle - Drug Effects
(6)
Deoxycytidine - Pharmacology
(6)
Drug Synergism
(6)
Gemcitabine
(6)
Middle Aged
(6)
Pharmacology & Pharmacy
(6)
Aged
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Correlation of CDA, ERCC1, and XPD Polymorphisms with Response and Survival in Gemcitabine/Cisplatin–Treated Advanced Non–Small Cell Lung Cancer Patients

Cellular and pharmacogenetics foundation of synergistic interaction of pemetrexed and gemcitabine in human non-small-cell lung cancer cells

Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer

Synergistic Cytotoxicity and Pharmacogenetics of Gemcitabine and Pemetrexed Combination in Pancreatic Cancer Cell Lines

Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines

Synergistic Antitumor Activity of ZD6474, An Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor Signaling, with Gemcitabine and Ionizing Radiation against Pancreatic Cancer

A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge

Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine

Synergistic cytotoxicity, inhibition of signal transduction pathways and pharmacogenetics of sorafenib and gemcitabine in human NSCLC cell lines

Akt1 rs2498801 is related to survival in head and neck squamous cell cancer treated with radiotherapy

Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer

Synthesis of Novel 3,5-Disubstituted-2-oxindole Derivatives As Antitumor Agents against Human Nonsmall Cell Lung Cancer

Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma

Cytotoxic activity of gemcitabine and correlation with expression profile of drug-related genes in human lymphoid cells

Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines

Synergistic Cytotoxicity and Molecular Interaction on Drug Targets of Sorafenib and Gemcitabine in Human Pancreas Cancer Cells

Cellular and Pharmacogenetics Foundation of Synergistic Interaction of Pemetrexed and Gemcitabine in Human NonâSmall-Cell Lung Cancer Cells

242: Pharmacogenetics Determinants of Anticancer Activity of Intravescical Gemcitabine in Patients with Superficial Transitional Cell Carcinoma (TCC) of The Bladder

D3-06: Correlation of cytidine deaminase and DNA repair genes polymorphisms with response and survival in gemcitabine/cisplatin treated advanced non-small-cell lung cancer patients

THE LEONARDO GALLERY

Homage to Escher

Suchergebnisse filtern